The British Pharmacopoeia Commission was established in 1970 under Section 4 of the Medicines Act 1968 to carry on the work of the previous Commission appointed by the General Medical Council (GMC). A Commission was first appointed by the GMC when the body was made statutorily responsible under the Medical Act of 1858 for producing a British Pharmacopoeia on a national basis.The British Pharmacopoeia Commission Laboratory (BPCL)
The Laboratory's principal role is in the procurement, establishment, maintenance and sale of British Pharmacopoeia Chemical Reference Substances (BPCRS)
The Laboratory also supports the work of the British Pharmacopoeia Commission (BPC) in the establishment of monographs for medicinal products available in the UK. The BPC are responsible for the publication of the British Pharmacopoeia, British Pharmacopoeia (Veterinary) and the production of British Approved Names. The BPC also participates in the work of the European Pharmacopoeia.
The BPC is part of the Medicines and Healthcare Products Regulatory Agency (MHRA), an executive agency of the Department of Health. The primary objective of the MHRA is to protect public health by ensuring that medicines, healthcare products and medical equipment are safe for those who use them.
The Medicines and Healthcare products Regulatory Agency is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe.